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ABSTRACT: SU-8 is an epoxy-novolac resin and a well established negative photoresist for 
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polymer showing outstanding chemical and physical robustness with residual surface epoxy groups 
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amenable for chemical functionalization. In this paper we describe, for the first time, the preparation and 
surface modification of SU-8 particles shaped as microbars, the attachment of appropriate linkers and 
the successful application of these particles to multistep solid-phase synthesis leading to 
oligonucleotides and peptides attached in an unambiguous manner to the support surface.   
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MANUSCRIPT TEXT  
Introduction 
SU-8 is a Novolac-Epoxy resin well established in the field of microfabrication and micropatterning as a 
negative photoresist.1-3 Commercially available formulations (Shell Chemical, MicroChem) provide a 
macromonomer 1 (Scheme 1) dissolved in γ-butyrolactone at different concentrations.1 These different 
formulations are spin-coated onto a wide range of substrates giving raise to a range of film thicknesses 
in the range 1 to 100µm, depending on the viscosity of the original solution and the spin speed.1-3 They 
also contain a photoacid to initiate polymerization of the epoxide groups upon UV exposure.1-3 The 
resulting polymerized resin is a highly crosslinked polymer, the hardness of which depends on the time 
and energy of the UV exposure and post-exposure baking times and temperatures.1-3 Photolithographic 
masks are used to pattern the SU8, producing well defined structures with high aspect ratio (ratio 
height/width) and excellent mechanical properties.2,3 Thus, SU-8 has been successfully fabricated into a 
range of microstructures including microfluidic structures,4,5 moulds and masters for microembossing,6,7 
probes for microscopy,8,9 and biosensors.10 Because of its outstanding performance in microfabrication, 
optical transparency in the visible range, and excellent physical and chemical stability, SU-8 has recently 
attracted attention for use in bioanalytical applications as a support for the direct attachment of 
biomolecules.11-16 After microfabrication, residual surface epoxy groups are suitable to act as reactive 
sites for surface functionalization.11,12  
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Unpolymerized SU-8 has been used in chip technology for DNA hybridization assays coated on glass.13-
15
 More recently, photopolymerized and structured SU-8 has been used for DNA hybridization.16 
Immobilization of DNA probes was carried out by spotting either amino-modified or unmodified 
oligonucleotides on the surface of SU-8 films and structures microfabricated through photolithography. 
This resulted in an uncertain mode of chemical attachment and indeterminate orientation of 
oligonucleotide probes on the SU-8 surface.16  In this paper we describe, for the first time, the 
preparation and surface modification of SU-8 particles shaped as microbars, the attachment of 
appropriate spacers in combination with linkers and the successful application of these particles to 
multistep synthesis leading to oligonucleotides and peptides attached in an unambiguous manner to the 
support surface. While SU-8 will probably not become a successful support for synthesis on its own 
right competing with optimized supports for synthesis, its establishment in microfabrication coupled 
with the feasibility of carrying out multistep synthesis enables access to interesting applications in 
bioanalytical sciences (e.g. microfabricated encoded carriers, microfluidic devices with in built 
molecular probes, etc).  
Results and discussion 
Fabrication of SU-8 microparticles 
The fabrication of SU8 microparticles suitable for multistep synthesis required significant optimization. 
The mask for the photolithographic process was designed to produce microparticles (cross section: 20 
µm x 10 µm) comparable in size to the beaded polymer supports used in conventional multistep solid 
phase synthesis. For a typical film height (3-4 µm) this results in 10 mg of particles per wafer. The 
microfabrication process exposes the particles to a wide range of physical and chemical conditions, 
some of which could potentially modify the surface properties of the particles and render them 
unsuitable for further chemistry.1-3 Therefore an important feature of this work was to determine 
whether the fabricated microparticles remained suitable for synthetic chemistry.  
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SU-8 microparticles were prepared by conventional photolithography (Figures 1 and 2a). In order to 
allow the release of microparticles from the substrate after microfabrication, a sacrificial layer was 
incorporated in the process, as shown in Figure 1. The selection of the sacrificial layer was based on 
good adhesion properties towards SU-8, ease of handling and simplicity of etching process.17-20 The last 
variable is critical and requires that the sacrificial layer is efficiently and rapidly removed, releasing the 
SU-8 particles into suspension without compromising the presence of residual surface epoxy groups to 
be used for functionalization.  
Initially, hard baked positive photoresist, S1813 was selected as a sacrificial layer.17  However, during 
the SU8 processing, some of the microparticles were released suggesting that the S1813 layer was 
insufficiently stable. Hard baking at an elevated temperature of 175°C for 1 h resulted in a significant 
improvement in the stability of the S1813 layer, but increased the difficulty of releasing the particles in 
the final lift-off phase.17  
As an alternative, the use of aluminum was investigated.18 A thin layer was evaporated onto a substrate, 
followed by spin coating with Ti primer prior to SU-8 processing, which resulted in excellent adhesion 
of the SU-8. After photopolymerization and a post-exposure bake, the non exposed areas were 
developed and the sacrificial layer etched. Clean etching of the aluminum layer was successful using an 
ultrasonic bath with commercial developer MF 319 (tetramethylammoniumhydroxide solution, TMAH).  
In all cases, the released SU-8 microparticles were collected by centrifugation, washed with methanol 
and then dried under vacuum to produce dry SU-8 support (Figure 2b). The yield of particles was 8 mg 
per wafer (80 %). 
Two batches of SU-8 microparticles were prepared by using two different sacrificial layers; one batch 
obtained using aluminum-coated wafers 2a and another obtained using S1813 as the sacrificial layer 2b 
(Scheme 2). The suitability of these two batches for peptide and oligonucleotide synthesis was then 
investigated.  
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Chemistry on SU-8 
Although optimization of the microfabrication was essential for optimal synthesis on SU8, chemical 
functionalization was first studied using large pieces of SU-8 prepared on S1813-coated glass. Films of 
SU-8 were produced this way by overexposure under UV and grinding the final film resin (100 µm 
thick) to small pieces (visually not more than 1 mm). This simpler process rapidly provided large 
quantities of material (SU-8, 3) for preliminary studies on the functionalization chemistry as shown in 
Scheme 2. It was anticipated that the straightforward chemistry of functionalization could subsequently 
be applied to well-defined and carefully microfabricated particles. The residual epoxy groups present on 
the surface of SU-8 were reacted with bisamines to introduce free amino groups selected (Scheme 2) 
using a similar procedure to that applied to other epoxide-containing polymer supports such as GMA 
(glycidyl methacrylate supports).21,22 1,3-diaminopropane (4a) and Jeffamine800 (4b) were selected as 
suitable amines and provided spacers of different lengths between the SU8 surface and the primary 
amine. The conditions resulting in the highest loading levels were found to be overnight stirring in 
acetonitrile at 65 oC.  Test washes with hot and cold acetonitrile and analysis of the washings suggested 
that the excess bisamine was thoroughly removed by series of simple washing/centrifugation cycles with 
acetonitrile at room temperature, although the possibility of permanent physical entrapment of the 
bisamines in the polymer network cannot be excluded. The loading levels of the amino supports (5) 
were approximately quantified using the ninhydrin test (Table 1). The use of 1,3-diaminopropane (4a) 
resulted in a loading level of 20 µmol/g, whilst Jeffamine800 (4b) gave a loading level of 9 µmol/g. The 
lower loading levels observed with Jeffamine800 (4b) may be rationalized in terms of the reduced 
accessibility of epoxide groups on the polymer to this bulkier nucleophile.  
The resultant amino groups were then coupled to N-Fmoc-6-aminohexanoic acid using standard 
carbodiimide/N-hydroxybenzotriazole (HOBt) chemistry.23 Quantitation of this reaction by release of the 
Fmoc group with piperidine in N,N-dimethylformamide (DMF) showed that while Jeffamine-derived 
aminosupport 5b led to quantitative coupling (relative to the initial loading levels), 1,3-diaminopropane-
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derived support 5a showed much lower coupling efficiency (Table 1).23 It may be that the smaller 
bisamine, whilst derivatizing the less accessible epoxy sites on the support, leads to amino groups that 
are not homogeneously reactive (e.g. amide formation).  For this reason the use of 1,3-diaminopropane 
was abandoned and all further synthetic studies made use of Jeffamine for the functionalization of the 
SU-8 resin. 
 Having demonstrated the feasibility of functionalizing SU-8 on this model material, further studies were 
carried out with microfabricated SU-8 particles. Microparticles prepared using aluminum (2a) and 
S1813 (2b) as sacrificial layers were treated with Jeffamine (4b) at 65 oC in acetonitrile overnight. 
Ninhydrin assay of the amino particles showed that 2b gave rise to higher loading amino-SU-8 (8b, 66 
µmol/g) compared to the particles developed on aluminum (8a, 22 µmol/g) (Table 1). This difference 
was consistent from batch to batch of SU-8 with 8b in the range of 40-70 µmol/g and 8a in the range of 
15-20 µmol/g amino groups. These low loading levels were expected as a consequence of surface-only 
functional sites. This is caused by the high levels of crosslinking and the fact that polymerization occurs 
in a thin film on the solid state with the absence of any porogen leaving accessible epoxy groups on the 
surface of the monolithic particles (See Figure 2). 
The initial functionalization was extended by attachment of a second spacer, N-Fmoc-6-aminohexanoic 
acid followed by capping the residual nucleophiles on the surface of the particles (Scheme 2). By 
cleaving the Fmoc group from a small aliquot of particles, the efficiency of this coupling reaction to 
form 9a and 9b (Scheme 2) could be determined. This experiment demonstrated that the 
microfabrication method had a profound impact on the reproducibility of subsequent chemistry: loading 
levels for 8a prepared with aluminum as sacrificial layer proceeds quantitatively (within experimental 
error). On the other hand, the use of S1813 as sacrificial layer (2b, 8b, 9b) led to poorly reproducible 
results, although sometimes the reactions were relatively high yielding. It was also observed that the 
SU8 prepared with an S1813 sacrificial layer appeared to have a higher loading level after the coupling 
of N-Fmoc-6-aminohexanoic acid (as quantified by the Fmoc test of 9b) than had been observed by the 
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ninhydrin test of 8b (Table 1). This can be most simply explained by the presence of additional non-
amine functionalized groups that undergo acylation by N-Fmoc-6-aminohexanoic acid. These results 
indicate that SU-8 particles prepared on Al as a sacrificial layer are more suitable for the development of 
robust and reliable solid-phase chemistry. 
Peptide synthesis 
To test the performance of SU-8 in multistep synthesis, solid-phase peptide synthesis was chosen as a 
well-established methodology,24 and the resultant peptides are attractive targets in a myriad of 
biotechnological assays and applications.25 Leucine-Enkephalin was selected as a simple test sequence. 
It is a pentapeptide (Tyr-Gly-Gly-Phe-Leu) that is routinely used as a model for testing materials as 
supports for synthesis.26-28 To permit Fmoc-chemistry, 4-hydroxymethylphenoxyacetic acid (HMPA) 
was attached as a linker using carbodiimide/HOBt chemistry at room temperature.23 (Scheme 3). The 
first aminoacid (N-Fmoc-Leu) was coupled onto the resin using carbodiimide/N,N-dimethyl-4-
aminopyridine (DMAP) at room temperature.23 A quantitative Fmoc test showed efficient loading of the 
first aminoacid (Table 1). Subsequent couplings were carried out using (N,N,N’,N’-tetramethyl-O-
benzotriazol-1-yl)uronium tetrafluoroborate (TBTU) as coupling reagent.23 Throughout the peptide 
synthesis, SU-8 prepared on aluminum (11a) showed a marked superiority over SU-8 microfabricated 
on S1813 (11b). The latter (SU-8/S1813, 11b) repeatedly gave inconclusive ninhydrin tests and 
couplings had to be repeated several times (Table 1). After the synthesis, the peptides were cleaved from 
the support using TFA/phenol (98:2). The available quantities of microparticles limited the synthesis to 
a very small scale (50 mg of SU-8 particles, 850 nmol scale synthesis) and this scale restricted the range 
of techniques available for product characterization. However, HPLC-MS analysis required very small 
quantities of material and allowed comparison of the synthetic peptide samples with a commercial 
sample of Leu-Enkephalin (Figure 3a,b). SU-8 microfabricated on aluminum (11a) produced Leucine-
Enkephalin (12a) essentially as a single peptide product (Figure 3c,d). The purity of 12a was low as can 
be seen from HPLC analysis but no other peptide impurities were detected (Figure 3a,b). Further 
 8
optimization will be required to minimise the level of impurities present, which we associate with leach 
of the support during TFA cleavage. Although necessary at this stage of evaluation, this step will not be 
carried out in analytical applications of microfabricated supports. The yield of product (12a) with 
respect to the loading of the first aminoacid was estimated to be 5 % by chromatographic comparison 
with a commercial standard (Figure 3a, c).  Although somewhat disappointing, this yield highlights the 
practical difficulties in isolating polar compounds such as peptides from manual nanomolar scale 
syntheses. A commercial sample of Leu-Enkephalin showed identical mass spectrometric and 
chromatographic properties to those found for 12a. SU-8 11b, prepared on S1813, yielded a mixture of 
peptides (12b) including some with a higher than expected molecular weight, with mass differences 
from Leu-Enkephalin consistent with the addition of extra Tyr and Gly residues (Table 1, Figure 3e,f). 
These LCMS results, combined with the observed inconclusive results from ninhydrin tests during the 
coupling reactions may indicate partial cleavage of Fmoc groups during couplings, leading to 
oligomerization of the same aminoacid onto the growing peptide chain, especially when couplings were 
repeated. With this result, it was concluded that the SU-8 microfabricated on S1813 (2b) was not 
suitable for use in multistep synthesis.  In contrast, SU-8 patterned on aluminum (2a) showed excellent 
properties as a support for multistep synthesis throughout the chemical transformations studied. 
Synthesis of a larger peptide was then explored to confirm the suitability of SU-8 prepared on Al for 
multistep synthesis. A nonapeptide (HIV-Protease 1 substrate), was chosen as the target (13, Val-Ser-
Gln-Asn-Tyr-Pro-Ile-Val-Gln).29-31 Nonapeptide 13 was synthesized on SU-8 prepared on Al (11a) since 
this had given the best results for the synthesis of Leu-Enkephalin (12) (Scheme 3). As peptide 13 was 
not commercially available, a synthetic standard of 14 was prepared by standard SPPS using standard PS 
resin with a Wang linker, 15. The synthesis of 13 proceeded smoothly requiring only single couplings.23 
The product peptides were analyzed by HPLC-MS after cleavage and the results are shown in Figure 4 
and Table 2. The yield of crude peptide 13 was higher than in the previous case (40 %) although equally 
impure. However, the major impurities are not peptide side products but support leach as stated before. 
As expected the crude product from conventional SPPS, 14, was relatively pure with a single minor 
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impurity. MS of the impurity was consistent with a dehydration product (possibly dehydration of Asn or 
Gln) (Figure 4c,d, Table 2). The nonapeptide synthesized on SU-8 (13) contained the same minor 
impurity. Identity of the sample prepared on SU-8 was further confirmed by co-elution of the crude 13 
with HPLC purified 14.  
Although the final yields from the nanoscale synthesis may not be comparable to well-established 
supports for solid-phase chemistry, the most important parameter for this study was the purity of target 
peptides in comparison to other peptide products and this was certainly satisfactory in the case of SU-8 
microfabricated on aluminum (11a). This proves the feasibility of using microfabricated SU-8 for the 
direct synthesis of analytical probes. The general purity of the products, though, was not satisfactory. 
However, as explained before, we believe that major impurities are based on support leach during 
cleavage conditions required at this stage for product analysis but avoided in analytical applications of 
the microfabricated surfaces. Further optimization to improve this situation will also be carried out.  
Oligonucleotide synthesis 
To demonstrate the flexibility of SU-8 as a support for solid-phase synthesis, oligonucleotides were 
targeted through the phosphoramidite approach.32,33 Amino-SU-8 (10a and 10b) was functionalized with 
succinimidyl nucleoside 16 to produce amide 17 (Scheme 4). The loading level was measured by release 
of dimethoxytrityl cation under acidic conditions and found to be 25 µmol/g.32 SU-8 17a and 17b were 
used in the synthesis of the following oligonucleotides: T15C 19a,b and GCTTATGCTTCTTC 20a,b. 
These structures were not based on natural sequences. In parallel to this synthesis the same 
oligonucleotide sequences were also prepared on pre-packed CPG columns (18, 1000 Å pore size, 50 
nmol scale from Bioautomation), producing oligonucleotides 19c and 20c). For the synthesis an 
automatic MerMade192 synthesizer (Bioautomation) was used following manufacturer protocols 
optimized for the synthesis on column CPG (18) and performing double phosphoramidite couplings on 
the SU-8 supports. After conventional synthesis (DMT off) and cleavage of the oligonucleotides from 
the support, the oligonucleotides were characterized by capillary electrophoresis (shown in Figure 5) and 
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MALDI-TOF MS.34-36 In agreement with earlier observations, SU-8 microfabricated on a S1813 layer 
17b was not suitable for synthesis, giving extremely low yields and poor purity of oligonucleotides 19-
20b (less than 3 % or not detected, data not shown). On the other hand, SU-8 prepared on an aluminum 
sacrificial layer 17a produced oligonucleotides 19a and 20a with results comparable to those obtained 
from CPG as shown in Figure 5 and Table 3. This indicates that SU-8 is suitable for oligonucleotide 
synthesis, although further improvements in the purity and yield can be anticipated once the 
oligonucleotide synthesis protocols are optimized for this substrate. 
Given the purity of products, though, it is important to note that SU-8 seems, at this stage of 
development, to be appropriate for the synthesis of short oligonucleotides. Larger oligonucleotides will 
result in an increased number of deletion sequences and even lower purity levels.  
Conclusions 
Fabrication of releasable SU-8 microparticles on silicon wafers was achieved using standard 
photolithography techniques. In this process, aluminum proved to be a suitable sacrificial layer for the 
release of bars from the silicon substrate using basic conditions leading to microparticles with good 
yielding performance in subsequent chemistry.  
The use of SU-8, a well-established material for microfabrication, has been demonstrated as a feasible 
support for peptide and oligonucleotide synthesis with good purity compared to possible side products, 
but low purity overall due to leach during cleavage of products. While at this stage we do not envisage 
SU-8 as a possible competitor for established supports, these important results demonstrate the 
combination of microfabrication and multistep solid-phase synthesis. This useful combination of 
properties is very suitable for application in a wide range of bioanalytical systems and processes.  
Experimental   
Microfabrication of SU-8 particles: The photoresist SU-8 (SU-8-2, SU-8-25 and SU-8-50) and 
developers (Microposit EC and propylenglycol methyl ether acetate, PGMEA) were supplied by 
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Chestech Ltd, UK.  Rohm and Haas S1813 and Microposit MF-319 (tetramethylammoniumhydroxide, 
TMAH) were obtained from Shipley Europe Ltd. The universal Ti primer and single sided polished 4 
inch (100 mm) silicon wafers (thickness: 525 ± 25µm) were purchased from Microchem Corp. and Si-
Mat Silicon Materials, Germany respectively. A Headway Research spinner and a SUSS Microtech 
Mask Aligner MA6 (lamp HG 1000 DC) were used for spinning and exposing the SU-8.  The photo-
mask (dark field) was designed to produce rectangular bars (20 x 10 µm) separated by a 10 µm spacing. 
It was generated using a CAD package (L-Edit 11.0) and printed on a glass-chromium photomask by 
Compugraphics International.  
Crosslinked SU-8 for functionalization studies: SU-8-50 (1 ml) was spun on thin objective 
microscope cover glass slides at 2000 rpm for 2 min. The slides were soft-baked at 95 oC for 30 min and 
exposed to UV light (100 W UV-vis bulb, cut-off filter 365 nm) for 5 min. The exposed slides were 
soft-baked at 95 oC for 30 min and the SU-8 was easily lifted off the glass slides by gently bending the 
slides. The crosslinked SU-8 films were ground to particle sizes not bigger than several hundreds µm 
(visually less than 1 mm).    
SU-8 microfabrication by photolithography: Standard photolithographic methods were used to 
fabricate the SU-8 micro-particles onto silicon wafers (4 inch) (Figure 1). A six step process was 
optimized as follows: (1) selection and coating of sacrificial layer, (2) optimization of adhesion of SU-8, 
(3) spin coating of SU-8, (4) photolithography, (5) development, and finally (6) the lift off process. 
Silicon wafers were cleaned by immersion in fuming nitric acid for 20 minutes and then rinsed twice in 
water. The acid cleaned wafers were then spun dry and baked at 200° C in a convection oven overnight.  
The wafers were then coated with sacrificial layers, either Al (50 nm) or S1813 resist. The S1813 (5-6 
ml) was spin coated onto pre-cleaned silicon wafers at 2000 rpm for 30 seconds. The wafers were then 
baked for 30 minutes at one of three temperatures:  95° C, 115° C or 175° C.   A 50 nm thick layer of Al 
was coated on to pre-cleaned silicon wafers using an E-Gun evaporator; the coated wafers were washed 
with acetone and isopropanol and blow dried.  Then the wafers were then baked at 200° C for 1 hour to 
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ensure dryness and a universal Ti primer (sufficient to coat the entire wafer, ~3 ml) was then spin coated 
onto the Al-coated wafers at 2500 rpm for 30 seconds. The resultant wafers were then baked at 120° C 
for 10 minutes in an oven.  
SU-8-2 was spin coated onto pre-cleaned and primed wafers using the spin cycle started from a spread 
cycle at 500 rpm for 5 seconds at an acceleration of 100 rpm per second followed by a final cycle at 
1500 rpm for 30 seconds at an acceleration of 300 rpm per second. A similar process was applied for 
spin coating SU-8-5 except that the final cycle was at 2500 rpm. After applying the SU-8 layer, the 
wafers were soft baked at 65° C for 3 minutes, and then the temperature was increased at 4 °Cmin-1 to 
95° C, then the temperature maintained for 5 minutes for SU-8-2 and 10 minutes for SU-8-5.  
The SU-8 coated wafers were exposed to 365nm light, optimized by varying the exposure time from 3- 
10 seconds with increments of 1 second (at the rate of 20.1 mW cm-2) with exposure doses between 90-
110 mJ cm-2.  After exposure, the wafers were baked at 65° C for 1 minute, and then the temperature 
was increased at 4° Cmin-1 to 95° C for 1 minute for SU-8-2 and 3 minutes for SU-8-5 respectively. The 
wafers were then left to cool to room temperature. The wafers were developed in PGMEA for 2 min 
with agitation, then thoroughly rinsed with isopropyl alcohol and blow dried. The sacrificial layer was 
removed by sonicating the wafers in TMAH (Microposit MF-319) at room temperature for 10 mins. The 
released microparticles were collected by centrifugation (13000 rpm for 1 min) and then washed in 
methanol (1 ml x 8 times) and dried under vacuum at room temperature for 4 h. The yield of isolated 
particles was typically 8 mg per wafer (80 %). 
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Chemistry on SU-8: All reactions were carried out in microcentrifuge tubes (1.5 ml) and separation of 
the support from solutions carried out by centrifugation at 13200 rpm for 1-3 minutes in an accuSpinTM 
Micro microcentrifuge (Fisher Scientific). Ninhydrin, Fmoc and trityl tests were carried out by UV 
spectrophotometry as reported in the literature.33,37,38  
Functionalization of fragmented SU-8: SU-8 (100 mg) was treated with Jeffamine800 (500 mg, neat) 
and acetonitrile (500 µl) and heated to 65 oC in an oven overnight. The support was washed with 
acetonitrile (7 x 800 µl) followed by methanol (7 x 800 µl) and dried under vacuum at room temperature 
for 4 h to yield 8a and 8b. N-Fmoc-6-aminohexanoic acid (5.0 mg, 14 µmol) was dissolved in DMF 
(100 µl) and N,N’-diisopropylcarbodiimide (DIC) (2 µl, 13 µmol) was added. The mixture was shaken 
for 8 min at room temperature, HOBt (2 mg, 15 µmol) was added and the mixture was shaken for 5 min 
at room temperature. The mixture was added to amino SU-8 (1.50 µmol based on free –NH2 groups) 
suspended in DMF (300 µl) and the mixture was heated to 60 oC for 1h. The support was washed with 
DMF (7 x 800 µl) followed by THF (7 x 800 µl). The support was then suspended in a freshly prepared 
solution of THF (1 ml) containing acetic anhydride (10 % v/v), 2,6-lutidine (11 % v/v) and N-
methylimidazole (16 % v/v) and shaken for 15 min at room temperature. The support was then washed 
with THF (2 x 800 µl) and the treatment with acetic anhydride, 2,6-lutidine and N-methylimidazole was 
repeated. The support was washed with THF (7 x 800 µl) followed by methanol (7 x 800 µl) and then 
dried under vacuum at room temperature for 4 h to yield 6a, 6b, 9a and 9b. Fmoc-SU-8 (less than 200 
mg) was suspended in piperidine (20 % in DMF, 1 ml) and shaken at room temperature for 20 min. The 
treatment with piperidine/DMF was repeated. The support was washed with DMF (10 x 800 µl) 
followed by tetrahydrofuran (THF) (8 x 800 µl) and diethyl ether (3 x 800 µl) and dried under vacuum at 
room temperature for 4 h to yield 7a, 7b, 10a and 10b. 
Attachment of HMPA linker (Synthesis of 11a and 11b): HMPA (8 mg, 45 µmol) was dissolved in 
DMF (100 µl) and DIC (7 µl, 45 µmol) was added. The mixture was shaken for 8 min at room 
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temperature, HOBt (6 mg, 45 µmol) was added and the mixture was shaken for 5 min at room 
temperature. The mixture was added to amino SU-8 (50 mg, 850 nmol based on free –NH2 groups) 
suspended in DMF (100 µl) and the mixture was shaken for 1 h at room temperature. The support was 
washed with DMF (7 x 800 µl) and the procedure was repeated. The support was washed with DMF (7 x 
800 µl) followed by methanol (7 x 800 µl) and dried under vacuum at room temperature for 4 h.  
Attachment of first aminoacid: N-Fmoc-Leucine (12 mg, 33 µmol) was dissolved in DMF (50 µl) and 
DIC (5 µl, 33 µmol) was added. The mixture was shaken for 8 min at r.t. DMAP (0.5 mg, 3 µmol) was 
added and the mixture was added to HMPA SU-8 (850 nmol based on loss of amino groups after the 
attachment of the linker) suspended in DMF (100 µl) and the mixture was shaken for 1h at room 
temperature. The support was washed with DMF (7 x 800 µl) and the procedure was repeated twice. The 
support was washed with DMF (7 x 800 µl) followed by methanol (7 x 800 µl) and dried under vacuum 
at room temperature for 4 h. 
Peptide synthesis: The following aminoacids were required: N-α-Fmoc-Leu, N-α-Fmoc-Gly, N-α-
Fmoc-Phe, N-α-Fmoc-Val, N-α-Fmoc-Gln, N-α-Fmoc-Asn, N-α-Fmoc-Pro, N-α-Fmoc-Ile, N-α-Fmoc-
(O-Trt)-Ser and N-α-Fmoc-(O-2-Cl-Trt)-Tyr.  N-α-Fmoc-aminoacid (8 µmol) was dissolved in DMF 
(50 µl) and TBTU (3 mg, 9 µmol), HOBt (0.3 mg) and N,N-diisopropyl-N-ethylamine (DIPEA) (1.5 µl, 
9 µmol) were added. The mixture was shaken for 2 min, then the mixture was added to the deprotected 
SU-8 (850 nmol based on –NH2 groups) suspended in DMF (100 µl) and the mixture was shaken for 1h 
at r.t. The support was washed with DMF (3 x 800 µl) followed by methanol (2 x 800 µl) and diethyl 
ether (3 x 800 µl). The completeness of the reaction was monitored by ninhydrin test. After a negative 
ninhydrin test the N-terminus Fmoc group was removed. The peptide was cleaved from the support by 
treatment with TFA/phenol (98/2 % v/w, 25 ml/g resin) for 90 min at room temperature. The support 
was filtered and washed with TFA (3 x 1 ml). The combined filtrates were evaporated under vacuum 
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and the residual oil was triturated with diethyl ether. The solid that precipitated was washed with diethyl 
ether and dried under vacuum at room temperature for 4 h. 
LC-MS analysis of peptides: dry samples were dissolved in acetonitrile/H2O (50/50 % v/v) (0.5 mg/ml). 
Analytical HPLC (Gilson) was monitored at 215 and 280 nm using a Phenomenex C18 column (150 x 
4.5 mm, 5 µm, 300 Å pore size). Gradient: 10-100 % B in A gradient over 32 minutes at 1 ml/min, 
where A: 0.1 % TFA /10 % acetonitrile/water and B: 0.1 % TFA/acetonitrile. The injection volume was 
200 µl. ESI-MS (Surveyor MSQ) was coupled online with the HPLC separation by a splitter (1/4 split) 
and mixing the chromatographic outlet with 0.3 % formic acid / 50 % acetonitrile / 50 % H2O in a third 
pump (1 ml/min). See main text for results. 
HIV Protease I substrate, 13, was further characterized by NMR spectroscopy using a Bruker 
spectrometer operating at either 400 MHz (1H) or 100 MHz (13C). 1H NMR (D2O) δ 7.06 (m, 2H, J = 
8.7 Hz), 6.78 (d, 1H, J = 8.6 Hz), 6.75 (d, 1H, J = 8.2 Hz), 4.74 (dd, 1H, J = 8.6, 5.6 Hz), 4.58 (dd, 1H, 
J = 7.9, 6.0 Hz), 4.45 (t, 1H, J =6 Hz), 4.36 (dd, 1H, J = 7.0, 6.4 Hz), 4.31 (dd, 1H, J = 9.0, 5.0 Hz), 
4.24 (dd, 1H, J = 8.4, 5.6 Hz), 4.11-4.03 (m, 2H), 3.79 (m, 3H), 3.67 (dd, 1H, J = 7.1, 16.5 Hz), 3.48 
(dd, 1H, J = 6.4, 16.0 Hz), 3.01 (dd, 1H, J = 5.0, 14.6 Hz), 2.79 (m, 1H), 2.68 (m, 1H), 2.56 (m, 2H), 
2.29 (m, 3H), 2.17 (m, 4H), 2.00-1.76 (m, 7H), 1.44 (m, 1H), 1.13 (m, 1H), 0.95 (m, 6H), 0.89-0.78 (m, 
12 H). 13C NMR (D2O) δ 178.0, 174.9, 174.6, 174.1, 173.9, 173.5, 172.1, 171.8, 171.5, 171.4, 169.8, 
154.8, 131.1, 130.9, 128.4,  61.4, 60.7, 59.7, 58.8, 58.7, 55.8, 53.4, 53.3, 52.4, 50.6, 48.3, 36.6, 36.4, 
35.9, 31.5, 31.3, 30.6, 30.3, 29.6, 27.2, 26.8, 25.1, 25.0, 18.7, 18.3, 18.2, 18.0, 17.1, 15.2, 10.5 
Synthesis of 17a and 17b: 3’-O-Succinimydyl-5’-O-dimethoxytrityl-N-benzoyl-deoxycytidine (8.0 mg, 
11 µmol) was dissolved in DMF (500 µl). HOBt (0.3 mg, 2 µmol), TBTU (3.5 mg, 11 µmol) and 
DIPEA (1.8 µl, 11 µmol) were added and the mixture stirred at room temperature for 5 min. The 
mixture was added to amino SU-8 10a (200 mg, 3.5 µmol based on –NH2 groups) and stirred vigorously 
at room temperature for 30 min. The support was washed with DMF (3 x 800 µl) and the procedure was 
 16
repeated. The support was washed with DMF (7 x 800 µl) followed by THF (7 x 800 µl) and dried under 
vacuum at room temperature for 4 h. 
Oligonucleotide synthesis, purification and analysis:36,39A MerMade 192 automatic synthesizer 
(Bioautomation Inc.) was used for oligonucleotide synthesis according to the manufacturer protocol for 
a 50 nmol scale synthesis optimized for MerMade CPG columns (1000 Å pore size, 50 nmol, standard 
CPG loaded with 3’-C). For SU-8 particles a modified protocol was used involving phosphoramidite 
double couplings. After the synthesis, the oligonucleotides were cleaved from the support using 
ammonia solution (35 %, 0.88 g/ml, 1 x 150 µl for 15 min, followed by 3 x 100 µl for 15 min, filtering 
and collecting the filtrate each time). The combined filtrates were heated in a sealed plate at 65 oC for 6 
hours. The solutions were freeze dried overnight and the residue dissolved in H2O (150 µl). The 
oligonucleotide solutions were purified by HPLC. Preparative HPLC (Gilson) was monitored at 254 and 
280 nm. Separation was carried out using a Phenomenex Jupiter C18 column (50 x 4.60 mm, 5 µm, 
300Å pore size). Gradient: 0-40 % B in A gradient over 8 minutes, isocratic at 40 % B in A for 30 sec, 
then 40-0 % B in A in 30 sec and isocratic at 100 % A for a minute, at 1 ml/min, where A: 0.1 M 
ammonium acetate pH 7 in water and B: 0.1 M ammonium acetate pH 7 in 50 % acetonitrile in water. 
The injection volume was 120 µl. Isolated peak detection allowed for collection of single peak fractions 
between 2-7 min. After freeze drying of the fractions they were analyzed by Capillary Electrophoresis 
using a Beckman-Coulter P/ACE MDQ Capillary Electrophoresis System following the manufacturers 
protocol using a Beckman eCAP ssDNA 100-R kit. Separation carried out in Tris-Borate urea (7M) 
buffer using an eCAP DNA 100 µm ID capillary (20 cm). Fresh eCAP ssDNA gel was loaded into the 
capillary under pressure (60 psi x 15 min) followed by equilibration of the capillary immersed in Tris-
Borate urea (7M) buffer at constant voltage (3kV, 0.17 min ramp, normal polarity x 5 min, followed by 
9kV, 0.17 min ramp, normal polarity x 10 min). Capillary temperature was set at a constant 30 oC. The 
sample (diluted to 0.5 OD at 254 nm) was loaded at constant voltage (10 kV x 2 sec, reverse polarity) 
and then separated at constant voltage (9 kV x 60 min, 0.17 min ramp, reverse polarity). UV monitoring 
 17
was carried out at 254 nm. Migration times were compared to a standard oligonucleotide ladder 
(Beckman-Coulter) and confirmed by co-migration of samples. Oligonucleotides were further 
characterized using a DYNAMO MS MALDI-TOF spectrometer as described elsewhere.36 Samples of 
T10, T15 and T20 were used as internal standards. 
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Figure 4  
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Figure 5 
 
            a)                                                                             b) 
 
Minutes
15 16 17 18 19 20 21 22 23 24 25 26 27
A
U
0.00
0.01
0.02
0.03
0.04
0.05
0.06
0.07
UV - 254nm
65B6colCPG
Minutes
16 17 18 19 20 21 22 23 24 25 26 27 28 29 30
A
U
0.016
0.018
0.020
0.022
0.024
0.026
0.028
0.030
UV - 254nm
CPG_14mer_
 
 
            c)                                                                              d) 
Minutes
15 16 17 18 19 20 21 22 23 24 25 26 27
A
U
0.010
0.015
0.020
0.025
0.030
0.035
UV - 254nm
66A1SU8prep
Minutes
16 17 18 19 20 21 22 23 24 25 26 27 28 29 30
A
U
0.005
0.010
0.015
0.020
0.025
0.030
UV - 254nm
D1main_270306_2_
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 23
SCHEMES: 
 
Scheme 1 
OOO
O O O
OOO
O O O
n
Ar3S       SbF6
UV
HIGHLY CROSSLINKED RESIN
1
OOO
O O O
O O
O O
O
cured SU8
SU8 macromonomer
2
n
O
O
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 24
 
Scheme 2 
O
R NH2H2N HN
R
H2N
HO
2a, prepared on Al
2b, prepared on S1813
3,   ground
4a, R1= (CH2)3
4b, R2=
8a, R2 (Al)
8b, R2, (S1813)
5a, R1, ground
5b, R2, ground
N
H
FmocHOOC
5
Ac
N
R
H
N
AcO
O
5
N
H
Fmoc
Ac
N
R
H
N
AcO
O
5
H2N
6a, R1, ground
6b, R2, ground
9a, R2, (Al)
9b, R2, (S1813)
7a, R1, ground
7b, R2, ground
10a, R2, (Al)
10b, R2, (S1813)
i)
ii) Ac2O
O O
 
 
 
 25
Scheme 3 
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FIGURE CAPTIONS  
Figure 1. Microfabrication of SU-8 particles by photolithography: (1) Add sacrificial layer (either 
Al or S1813); (2) Add SU-8 and bake; (3) Expose to UV and bake; (4) Develop non crosslinked SU-8; 
(5) Etch sacrificial layer.  
Figure 2. Scanning Electron Microscopy Analysis of SU-8 microparticles prepared on an Al 
sacrificial layer: (a) SU-8 particles on Si-wafer after microfabrication (size bar: 30 µm); (b) SU-8 
particles after functionalization with Jeffamine (size bar: 20 µm). (c) Close section of SU-8 particle 
showing monolithic structure with lack of porosity. 
Figure 3. HPLC-MS Analysis of Leu-Enkephalin: (a) HPLC standard Leu-Enkephalin; (b) total ion 
current (TIC) standard Leu-Enkephalin; (c) HPLC 12a (synthesis on SU-8 (Al); (d) TIC 12a (synthesis 
on SU-8 (Al); (d) HPLC 12b (synthesis on SU-8 (S1813); (e) TIC 12b (synthesis on SU-8 (S1813). 
Note: HPLC trace corresponds to UV detection at 215 nm. The arrow indicates the target material. 
Figure 4. HPLC-MS Analysis of HIV-Protease I substrate: (a) HPLC 14 (Wang resin product); (b) 
total ion current (TIC) 14 (Wang resin product); (c) HPLC 13 (SU8 product); (d) TIC 13 (SU8 product). 
Note: HPLC trace corresponds to UV detection at 215 nm. The arrow indicates the target material. 
Figure 5. Capillary Electrophoresis of oligonucleotides. (a) Sequence 19 synthesized on 18 (column 
CPG); (b) sequence 20 synthesized on 18 (column CPG); (c) sequence 19 synthesized on 17a (SU-8); 
(d) sequence 20 synthesized on 17a (SU-8).   
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SCHEME TITLES: 
Scheme 1. Polymerization of SU-8 
Scheme 2. Functionalization of SU-8 
Scheme 3. Peptide synthesis on SU-8 
Scheme 4. Oligonucleotide synthesis on SU-8 
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TABLES: 
Table 1 
Reaction type/Process 
stage Loading levels of Supports (method of measurement, observations) 
Starting material 3 3 2a 2b 
Functionalization with 
bisamine 
5a, 
20 ± 3 
µmol/g 
(Ninhydrin) 
5b, 
9 ± 3 µmol/g 
(Ninhydrin) 
8a, 
15-25 µmol/g 
(Ninhydrin) 
8b, 
40-70 µmol/g 
(Ninhydrin) 
Attachment of Fmoc-
Aminohexanoic acid 
6a, 
4 ± 2 µmol/g 
(Fmoc) 
6b, 
9 ± 2 µmol/g 
(Fmoc) 
9a, 
15-19 µmol/g 
(Fmoc) 
9b, 
50-100 µmol/g 
(Fmoc) 
Deprotection of amino 
groups 7a 7b 
10a, 
16-18 µmol/g 
(Ninhydrin) 
10b, 
50-60 µmol/g 
(Ninhydrin) 
Attachment of HMPA 
linker   11a 11b 
Attachment of first 
aminoacid (Leu)   
15 µmol/g 
(Fmoc) 
60 µmol/g 
(Fmoc) 
Attachment of Phe   Single coupling Coupling repeated 
Attachment of Gly   Single coupling Single coupling 
Attachment of Gly   Single coupling 
Coupling repeated, 
intensity of ninhydrin 
test is faint after 
deprotection of Fmoc 
group 
Attachment of Tyr   Single coupling Coupling repeated 3 times 
Peptide cleavage   
12a, 0.5 mg crude 
isolated (expected 
0.5 mg, but only 5 % 
calculated from 
HPLC trace). ESI-
MS: Found 556.5 
(MH+) (Expected 
556.63) 
12b, 1.0 mg crude 
peptide isolated (30 
% calculated from 
HPLC trace). ESI-
MS: Found 613.57 
(MH++Gly). 719.68 
(MH++Tyr), 776.68 
(MH++Tyr+Gly), 
833.73 
((MH++Tyr+2Gly), 
     
Table 1. Functionalization of SU-8. Solid-phase synthesis of Leu-Enkephalin 
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Table 2 
HIV 
Protease I 
substrate 
(support) 
Yield 
% Overall 
Purity of 
nonapeptide 
Overall % of 
Elimination 
product 
% 
Nonapeptide 
with respect 
to other 
peptides 
(ESI-MS) 
% 
Elimination 
product with 
respect to 
other 
peptides 
(ESI-MS) 
% Main peptide 
impurityc 
(ESI-MS) 
13 (SU-8 
11a) 40 %
a
  29  11  
58 
(ESI-MS: 
Found 
1046.9(M+) 
(Expected 
1047.19) 
15 
(ESI-MS: 
Found 
1028.6(M+) 
(Expected 
1029.17) 
15 (ESI-MS: Found 610.0 
possible Val-Ser-Gln-
Asn-Tyr (M+) (Expected 
609.64) 
14 (Wang 
15) 87 %
b 67  23  
88 
(ESI-MS: 
Found 
1046.7(M+) 
(Expected 
1047.19) 
12 
(ESI-MS: 
Found 
1028.9(M+) 
(Expected 
1029.17) 
0 
       
Table 2. Solid-phase synthesis of HIV-Protease I substrate. Notes: a Estimated from integration of HPLC trace 
compared to calibrated data with pure 14. b Estimated from weight of crude. c Excluding elimination product. 
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Table 3 
 Results 
 
Oligonucleotide 
sequence 
(support) 
Purity of target 
oligonucleotide 
(%)a 
Mass by MALDI-
TOF (Expected)b 
% of principal impurity (length in 
bases)a 
1 19a (17a) 47 4791.5 (4791.2) 15 (13) 
2 19c (18) 77 4791.1 (4791.2) 6 (15) 
3 20a (17a) 56 4196.6 (4196.8) 20 (5)c 
4 20c (18) 91 4196.6 (4196.8) 3 (11) 
     
Table 3. Solid-Phase Synthesis of oligonucleotides on SU-8. Comparison with CPG. Notes: a Estimated 
from CE data b Corresponds to (MH)+ c Estimated from HPLC data (not shown). 
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